Synopsis of recent research by authors named "Leela Talluri"
- Leela Talluri's recent research primarily focuses on the safety, efficacy, and immunogenicity of various pharmaceutical treatments across multiple health conditions, including solid malignancies, allergic rhinitis, COVID-19, functional dyspepsia, major depressive disorder, chronic kidney disease, hypertension, and rheumatoid arthritis.
- Findings from her studies, such as the evaluation of Bevacizumab in solid tumors and the fixed-dose combination of Bilastine-Montelukast for allergic rhinitis, demonstrate significant advancements in treatment options while highlighting the importance of ongoing safety assessments in larger patient populations.
- Talluri's work contributes to the body of evidence supporting the use of newer drugs and combinations, and her investigations into post-marketing studies suggest a focused approach on real-world applicability and long-term outcomes of these treatments within diverse Indian populations.
